Table 1.
Baseline characteristics of the study population (N=5677).
Characteristic | Participants | ||
Female, n (%) | 3945 (69.5) | ||
Age, n (%) |
|
||
|
18-24 years | 1712 (30.2) | |
|
25-34 years | 2025 (35.7) | |
|
35-44 years | 1104 (19.4) | |
|
45-54 years | 534 (9.4) | |
|
55-64 years | 256 (4.5) | |
|
≥65 years | 46 (0.8) | |
Educational status, n (%) |
|
||
|
Primary school |
11 (0.2) |
|
|
Intermediate school | 68 (1.2) |
|
|
High school | 1341 (23.6) |
|
|
College/higher education | 4257 (75.0) | |
Work or study in the health care sector, n (%) |
|
||
|
Yes | 1250 (22.0) |
|
|
No |
4427 (78.0) |
|
Medical problems, n (%)
|
|
||
|
I have no medical problems | 4003 (70.5) | |
|
I have medical problems | 1674 (29.5) | |
Type of medical problemsa, n (%) |
|
||
|
High blood pressure | 387 (23.1) | |
|
Diabetes | 362 (21.6) | |
|
Heart disease | 74 (4.4) | |
|
Lung disease | 198 (11.8) | |
|
Cancer | 31 (1.9) | |
|
Other | 946 (56.5) | |
Country/region of current residence, n (%) |
|
||
|
Bahrain | 3179 (56.0) | |
|
Kuwait | 784 (13.8) | |
|
Saudi Arabia | 693 (12.2) | |
|
United Arab Emirates | 324 (5.7) | |
|
Oman | 232 (4.1) | |
|
Qatar | 71 (1.3) | |
|
Other Arab countries | 166 (2.9) | |
|
Asian countries (excluding Arab countries) | 43 (0.8) | |
|
Europe | 118 (2.1) | |
|
North America | 58 (1.0) | |
|
South America | 2 (0) | |
|
Australia and New Zealand | 7 (0.1) | |
COVID-19 diagnosis, n (%) |
|
||
|
Yes | 55 (1.0) | |
|
No | 5622 (99.0) |
an=1674.